Richard Fuller
Corporate Officer/Principal en The Royal College of Physicians .
Perfil
Richard Fuller is Chief Executive Officer of Oriel Therapeutics, Inc. and a Fellow of the Royal College of Physicians.
Prior to joining Oriel Therapeutics, he was Head of the Respiratory Clinical Group for Glaxo (now GlaxoSmithKline) and an Executive Director of the Wellcome Trust.
Previously, he was a Director and an Independent Consultant of Science Funding.
Dr. Fuller received a BSc degree in Immunology from University College London, an MBBS from the St. Georges Hospital Medical School London and an MD from the University of London.
Cargos activos de Richard Fuller
| Empresas | Cargo | Inicio |
|---|---|---|
| The Royal College of Physicians | Corporate Officer/Principal | 17/04/2009 |
Antiguos cargos conocidos de Richard Fuller.
| Empresas | Cargo | Fin |
|---|---|---|
The Wellcome Trust Ltd.
 The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Director/Miembro de la Junta | - |
Oriel Therapeutics, Inc.
 Oriel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oriel Therapeutics, Inc. develops inhaled drug delivery systems for respiratory diseases and diagnostics. It is a respiratory drug delivery and development company serving the pharmaceutical, biotechnology and diagnostic industries in the development and commercialization of innovative pre-metered unit and multi-dose dry powder delivery systems for medicines for asthma and chronic obstructive pulmonary disease. The company was founded by Paul J. Atkins, Timothy M. Crowder, Richard Fuller and Anthony J. Hickey in 2002 and is headquartered in Durham, NC. | Fundador | - |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Aerovance, Inc.
 Aerovance, Inc. Medical DistributorsDistribution Services Aerovance, Inc. develops drugs for respiratory and inflammatory diseases. The company was founded by Jeffrey Howard Tepper and Wolf-Dieter Busse in July 29, 2004 and is headquartered in Berkeley, CA. | Director Técnico/Científico/I+D | - |
Formación de Richard Fuller.
| University College London | Undergraduate Degree |
| University of London | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Aerovance, Inc.
Aerovance, Inc. Medical DistributorsDistribution Services Aerovance, Inc. develops drugs for respiratory and inflammatory diseases. The company was founded by Jeffrey Howard Tepper and Wolf-Dieter Busse in July 29, 2004 and is headquartered in Berkeley, CA. | Distribution Services |
Oriel Therapeutics, Inc.
Oriel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oriel Therapeutics, Inc. develops inhaled drug delivery systems for respiratory diseases and diagnostics. It is a respiratory drug delivery and development company serving the pharmaceutical, biotechnology and diagnostic industries in the development and commercialization of innovative pre-metered unit and multi-dose dry powder delivery systems for medicines for asthma and chronic obstructive pulmonary disease. The company was founded by Paul J. Atkins, Timothy M. Crowder, Richard Fuller and Anthony J. Hickey in 2002 and is headquartered in Durham, NC. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Miscellaneous |
- Bolsa de valores
- Insiders
- Richard Fuller
